Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Alvarez

Showing results (331-340 of 382) with videos related to

Pageof 39
Sort By:
Pilot and Feasibility Studies|March 29, 2022
The MultimorbiditY COllaborative Medication Review And DEcision Making (MyComrade) study: a protocol for a cross-border pilot cluster randomised controlled trialLisa Hynes, Andrew W Murphy, Nigel Hart, et al.
British Journal of Cancer|March 12, 2020
Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compressionPierre G Thirion, Mary T Dunne, Paul J Kelly, et al.
Molecular & Cellular Proteomics : MCP|June 29, 2026
Platelet proteome links metabolism to reactivity in Essential ThrombocythemiaXiomara Guerrero-Carreño, Sanne Smits, Alfonso Esteban Lasso, et al.
Open Biology|December 23, 2016
piRNA-associated proteins and retrotransposons are differentially expressed in murine testis and ovary of aryl hydrocarbon receptor deficient miceEva M Rico-Leo, Nuria Moreno-Marín, Francisco J González-Rico, et al.
Medicine|April 13, 2021
Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthoodBeatriz Ruiz-Saez, Manuela Martín-Bejarano García, Ana Martinez de Aragon, et al.
British Journal of Haematology|April 19, 2017
Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopeniaJuan-Carlos Hernández-Boluda, Juan-Gonzalo Correa, Alberto Alvarez-Larrán, et al.
Annals of Hematology|October 20, 2022
Correction to: Low‑risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia VeraAna Triguero, Alexandra Pedraza, Manuel Perez-Encinas, et al.
Journal of Clinical Pathology|June 24, 2018
Essential thrombocythaemia with mutation in <i>MPL</i>: clinicopathological correlation and comparison with <i>JAK</i>2V617F-mutated and <i>CALR-</i>mutated genotypesAlberto Alvarez-Larran, Daniel Martínez, Leonor Arenillas, et al.
Future Oncology (London, England)|August 11, 2022
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosisClaire N Harrison, Vikas K Gupta, Aaron T Gerds, et al.
American Journal of Hematology|June 21, 2021
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis RegistryJuan-Carlos Hernández-Boluda, Arturo Pereira, Nicolaus Kröger, et al.
Pageof 39

Showing results (331-340 of 382) with videos related to

Sort By:
Pageof 39
Pilot and Feasibility Studies|March 29, 2022
The MultimorbiditY COllaborative Medication Review And DEcision Making (MyComrade) study: a protocol for a cross-border pilot cluster randomised controlled trialLisa Hynes, Andrew W Murphy, Nigel Hart, et al.
British Journal of Cancer|March 12, 2020
Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compressionPierre G Thirion, Mary T Dunne, Paul J Kelly, et al.
Molecular & Cellular Proteomics : MCP|June 29, 2026
Platelet proteome links metabolism to reactivity in Essential ThrombocythemiaXiomara Guerrero-Carreño, Sanne Smits, Alfonso Esteban Lasso, et al.
Open Biology|December 23, 2016
piRNA-associated proteins and retrotransposons are differentially expressed in murine testis and ovary of aryl hydrocarbon receptor deficient miceEva M Rico-Leo, Nuria Moreno-Marín, Francisco J González-Rico, et al.
Medicine|April 13, 2021
Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthoodBeatriz Ruiz-Saez, Manuela Martín-Bejarano García, Ana Martinez de Aragon, et al.
British Journal of Haematology|April 19, 2017
Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopeniaJuan-Carlos Hernández-Boluda, Juan-Gonzalo Correa, Alberto Alvarez-Larrán, et al.
Annals of Hematology|October 20, 2022
Correction to: Low‑risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia VeraAna Triguero, Alexandra Pedraza, Manuel Perez-Encinas, et al.
Journal of Clinical Pathology|June 24, 2018
Essential thrombocythaemia with mutation in <i>MPL</i>: clinicopathological correlation and comparison with <i>JAK</i>2V617F-mutated and <i>CALR-</i>mutated genotypesAlberto Alvarez-Larran, Daniel Martínez, Leonor Arenillas, et al.
Future Oncology (London, England)|August 11, 2022
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosisClaire N Harrison, Vikas K Gupta, Aaron T Gerds, et al.
American Journal of Hematology|June 21, 2021
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis RegistryJuan-Carlos Hernández-Boluda, Arturo Pereira, Nicolaus Kröger, et al.
Pageof 39